Transforming the Battle Against Pancreatic Cancer
Our mission
At Galen Health, we pioneer technological breakthroughs in the early detection and prevention of pancreatic cancer, offering hope and saving lives.
Our mission is simple:
End pancreatic cancer.
Why pancreatic cancer?
Pancreatic ductal adenocarcinoma has one of the lowest survival rates of any major cancer for a devastating yet simple reason: it's a silent killer, detected too late.
With no early symptoms and no reliable screening methods, over 80% of cases are discovered only after the cancer has spread. At this point, survival rates plummet below 10%.
But there's hope: when detected early, survival rates increase dramatically. And if it is detected before it spreads, some patients can get treatment that completely cures it.
We're building AI that makes this possible. By enabling earlier detection, we can give more patients a fighting chance at survival and transform a diagnosis that today is often fatal into one that's potentially curable.
Pancreatic cancer is a death sentence.
At Galen Health, we have the power to grant a pardon.
Partner With Us
Whether you're a healthcare provider interested in our technology, a potential partner institution, or someone passionate about our mission to transform pancreatic cancer detection, we'd love to hear from you.
Share your info and our team will be in touch.
Make an impact today
Pancreatic cancer is often diagnosed too late. We're developing AI technology to detect it earlier, when treatment is most effective. Help fund critical research and development that could save thousands of lives.
Every month of earlier detection can increase survival rates by 10-20%. Your support helps.
Note: As we are a for-profit company developing healthcare technology, contributions are not tax-deductible. Your support directly funds our research and development efforts.